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The major histocompatibility  complex (MHC) class I molecules are the primary 
determinants recognized by allogeneic cytotoxic T lymphocytes (CTL), and serve 
as restricting elements for CTL recognition of viral, chemical, or minor histo- 
compatibility antigens (1).  Our  understanding of the  manner  in  which  these 
molecules participate in immune responses has been significantly advanced by 
the  development of techniques  for  expressing  MHC  genes  following  DNA- 
mediated transfer into suitable recipient cells (2-4). More recently, transfections 
have been undertaken with genes that have been manipulated in vitro to produce 
novel structures. Results from such studies have shown that the major determi- 
nants recognized by murine CTL lie in the highly polymorphic oq  and/or 0/2 
domains (5-9).  However, similar analyses of human CTL recognition of trans- 
fected  HLA  molecules  have  been  more  difficult to  interpret.  A  number  of 
investigators (i 0, 1 I) have shown that human HLA-A2 and -B7 genes transfected 
into murine L  cells are not recognized by human allogeneic CTL, suggesting 
that species-restricted factors may play a role in the cellular but not serological 
recognition of human MHC class I molecules. In contrast, others have reported 
(12,  13) that HLA-A3 and -Aw24 transfected into and expressed by murine L 
cells can be recognized by human CTL. Thus, it appears that properties of the 
recipient cell and/or a particular HLA molecule can affect the ability of human 
CTL to recognize transfected HLA genes. 
We have previously shown (14) 1  that HLA-Aw69 is a naturally occuring hybrid 
class  I  molecule, in that the al  domain is identical to that of HLA-Aw68, and 
the  a2  and  a3  domains  are  identical  to  those  of  HLA-A2.  To  localize  the 
functional determinants recognized by human allogeneic CTL, we used human 
B  iymphoblastoid cell  lines, which normally express these  HLA molecules, as 
stimulators to generate CTL clones, and as targets to assess CTL specificity. We 
show here that human CTL clones can recognize determinants in either the 0/1 
or  ol  2  domains, and that interaction of the 0/1  and 0/2 domains can result in the 
formation of determinants or the loss of preexisting determinants. 
Materials and Methods 
Cell  Lines.  CTL clones  were  generated as  described  previously  (15, 16). Briefly, 
peripheral  blood lymphocytes from a normal donor (HLA-A3,-; B7,w38; C-,-; DR6,6) 
i N. Holmes and P. Parham. Exon shuffling  in vivo can generate novel HLA class 1 molecules. 
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were  separated  on  Ficoll-Hypaque and  stimulated  in  primary culture  with  irradiated 
(10,000 rad) B lymphoblastoid cells expressing HLA-A2, -Aw68, or -Aw69. After 6 d, 
cells were stimulated in secondary culture with a different irradiated B lymphoblastoid 
cell, and 6 d later were cloned by limiting dilution on a third irradiated B lymphoblastoid 
cell  in  medium  supplemented  with  T  cell growth factors,  including interleukin  2.  18 
different combinations were used to generate the clones tested. For example, some CTL 
in group 1 were stimulated in primary culture with JY, secondary culture with LB, and 
cloned on LCL-721. Clones, which arose at 1 cell/well, were expanded in microtiter wells 
and  tested  for cytolysis of appropriate  target  cells  using  a  5~Cr-release  assay.  Clones 
exhibiting  desired  specificities  were  expanded  and  subcloned.  Clones  arising  at  0.3 
cells/well were expanded and retested for cytotoxicity against  10 lines expressing HLA- 
A2, 10 lines expressing HLA-Aw68, 6 lines expressing HLA-Aw69, and 3 lines expressing 
different HLA-A locus genes. 
B cell lines expressing the HLA-Aw69 antigen were kindly provided by F. Ward (Duke 
University, Durham, NC) (JSM);  P. Antonelli and J. Hansen (University of Washington, 
Seattle, WA) (BJ, ZM, HS, SR); and the American Type Culture Collection (Rockville, 
MD) (IDF). B cell lines expressing HLA-Aw68 were obtained from F. Bach and M. Segall, 
University of Minnesota. 
The expression of HLA-Aw68, -Aw69, and -A2 was confirmed by radioimmune cell- 
binding assay with appropriate monoclonal antibodies (mAb). 
Cytotoxicity Assay.  Clones were incubated at a variety of effector/target ratios with a 
panel of "~ZCr-labelled B lymphoblastoid cell lines. Cytotoxicity assays were carried out as 
described previously (15,  16). Percent specific release was calculated as  100 x  [(experi- 
mental release -  spontaneous release)l/[(Triton X-100 release -  spontaneous release)]. 
Values are expressed as means of triplicate cultures. 
Results and Discussion 
HLA-A2 and -Aw68 are highly homologous, as shown by the schematic of the 
protein sequences (14,  17) 1 (Fig.  1). There are six amino acid differences in the 
~1  domain,  six  in  the  OL  2  domain,  and  one in  the  c~3 domain.  CTL specific for 
HLA-A2, -Aw68, and/or -Aw69 were generated by stimulating peripheral blood 
lymphocytes from a  normal donor (HLA-A3,-; B7,w38; C-,-; DR6,6) in primary 
culture  with  irradiated  Epstein  Barr  virus-transformed  B  lymphoblastoid  cell 
lines expressing HLA-A2, -Aw68, or -Aw69 (HLA shown in Table I). Cells were 
stimulated in secondary culture with a different B  lymphoblastoid cell line, and 
were  cloned  by  limiting  dilution  using  a  third  B  lymphoblastoid  line.  Clones 
arising  at  1  cell/well  were  screened  for  cytotoxicity on  a  panel  of cell  lines 
a 1  90  a 2  180  ~3  270 
I  I  I  I 
HLA-Aw681  I  lilt  Ilul.  i  II  i  • 
FIGURE  l.  Schematic comparison of the deduced protein sequences of HLA-A2, -Aw68, and 
-Aw69. The anaino acid sequences of the three external domains (residues 1-270) of the HLA 
molecules -A2, -Aw68, and -Aw69 are compared schematically. Each vertical bar represents a 
single amino acid difference with the prototype HLA-A2 sequence from LCL-721; the HLA- 
Aw68 sequence is  fi'om the cell  line  LB;  the  HLA-Aw69 from BJ.  The  HLA-A2-identical 
domains are shaded and the HLA-Aw68-identical domains unshaded. The transmembrane 
and cytoplasmic domains are not shown. CLAYBERGER  ET  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  I 
Specificity of Anti-HLA-A2, -Aw68, and -Aw69 CTL 
1711 
Target cells 
ttLA  JY  LCL-721  LB  LCL-100  JSM  IDF  BJ  PGF  K562 
A  2  1, 2  w68  w68, 32  w69, w25  w69, 26  w69, w30  3  -- 
B  7  8, 5  40  44, 27  14, w22  38,  18  w35, w22  7  -- 
C  NA*  NA  3  2  wl, w8  NA  w6, w7  2  -- 
DR  4,6  3,1  6  2,5  7  5  2  2  -- 
(;roup  Percent specific release 
1  159  62 I  7  1  0  1  0  0  3 
2  [56  21  25  59 I  0  0  4  2  3 
3  [70  53  71  76  80  81  69[  3  0 
4  1  9  [39  43  56  59  471  6  3 
5  3  5  9  4  I44  43  291  6  4 
6  I77  56]  3  0  123  54  47]  4  2 
Results are of a single clone representative of each group and tested at an effector/target ratio of 5:1. 
* NA, data not available. 
expressing  HLA-A2, -Aw68,  -Aw69,  and  other  HLA types.  Clones exhibiting 
desired  cytotoxic specificities were subcloned at  0.3  cells/well.  No  changes  in 
specificity were  observed  following  subcloning.  In  addition,  mAb  PA2.6  and 
TSI.16  were used to confirm  the class I specificity of these CTL.  In all cases, 
cytotoxicity was inhibited by PA2.6 (anti-class I) but was unaffected by TS1.16 
(anti-class II). The cell surface phenotype of all CTL was 100% Leu-2  +, Leu-3-, 
Leu-4  +, as determined by fluorescence activated cell sorter analysis (not shown). 
93  clones were initially  assayed for cytotoxicity. 21  were not cytotoxic, and 
thus were not studied further. The remaining 72 clones were tested for cytotox- 
icity against  10  lines  expressing  HLA-A2,  10  lines  expressing  HLA-Aw68,  6 
lines expressing HLA-Aw69, and  3 lines that do not express HLA-A2, -Aw68, 
or -Aw69.  Representative results from such analyses are shown in Table  I and 
are summarized in Table II. 
CTL  clones  exhibiting  six  of the  seven  possible  patterns  of cytolysis were 
identified.  Clones  restricted  largely  by the  al  domain  (group  4)  or by the  O/2 
domain  (group  6) were identified.  CTL  in  group  1 may be specific for the 0/~ 
domain of HLA-A2 alone, or some combinational determinant comprised of 0/~ 
plus 0/2. In addition,  some CTL recognized determinants  that  were dependent 
on both the oq and  OL  2  domains. The determinant  recognized by CTL in group 
5 (HLA-Aw69 specific) is found only on the hybrid molecule. In contrast,  CTL 
in group 2 lyse targets expressing HLA-A2 or -Aw68, and not those expressing 
HLA-Aw69. Their target determinant  therefore is not present in the recombi- 
nant HLA-Aw69 molecule. CTL in group 3 recognize targets expressing HLA- 
A2,  -Aw68,  and -Aw69,  suggesting  that  these CTL are  restricted  by a  shared 
determinant.  This determinant  may be identical  to that recognized by B cells, 
since many anti-HLA-A2 mAb bind to both HLA-Aw68 and -Aw69 (18). Finally, 
no CTL  specific for  HLA-Aw68 alone  (group  7) were identified.  Since  other 
CTL specific for the O/2 domain were generated (group 6), this finding does not 1712  CLAYBERGER  El"  AL.  BRIEF  DEFINITIVE  REPORT 
TABLE  II 
Summary of Specificities ofT Cell Clones Screened 
Number of  Major restriction 
Group  HLA types lysed  element(s)  clones 
identified 
1  A2  al or oq +  a~  19 
2  A2, Aw68  oq +  as  9 
3  A2, Aw68, Aw69  a~ and/or as  13 
4  Aw68, Aw69  aT  1 
5  Aw69  a~ +  c~  7 
6  A2, Aw69  as  6 
7  Aw68  as or al +  as  0 
8  Unclassified  ?  17 
9  Noncytotoxic  ?  21 
Total:  93 
Clones derived  and  tested  as described  in  Table  I  were grouped by their  HLA 
specificity. Only CTL clones that lysed all  members of the  specificity panel  were 
included in  groups  1-6; CTL  that lysed one or  two lines expressing a  particular 
HLA type are grouped as unclassified, and are presumed to be specific for other 
antigens expressed on those target cells. 
reflect an intrinsic lack of antigenicity of the at2 domain. In our study, CTL were 
derived from peripheral  blood lymphocytes that type as HLA-A3. Comparison 
of the protein sequences of HLA-A2, -Aw68, and -A3 (19) offers some insight 
into our inability to generate group 7 CTL. There are six amino acid differences 
between HLA-Aw68 and -A2 in the second domain,  five of which occur in the 
region  including  residues 95-116.  Interestingly,  there  is only one amino  acid 
difference between HLA-A3 and -Aw68 in this  region.  It is therefore possible 
that lymphocytes from individuals expressing HLA-A3 cannot see this region as 
antigenic.  It  is also possible that  our sample of 72  CTL  clones was not  large 
enough to include CTL specificities that occur in low frequency. 
This is the first examination  of human  CTL recognition  of a  hybrid human 
class I molecule expressed in human cells; other investigations (4-9) have involved 
murine or xenogeneic systems, tn this particular system, we avoid the two major 
problems  of  gene  manipulation,  transfection,  and  expression.  By  using  the 
product of a natural exon shuffle, we are studying a functionally relevant hybrid 
gene that has survived evolutionary selection pressure, rather than hybrid genes 
produced by in vitro manipulation  of DNA, which are determined by available 
restriction  enzyme sites.  Second,  the hybrid  HLA-Aw69 gene and  the  related 
-A2 and -Aw68 genes are naturally expressed in human  B lymphoblastoid cells, 
the targets conventionally used for study of the human  allogeneic response.  In 
this way, we have avoided problems inherent in systems involving gene transfec- 
tion and expression, such as the role of accessory molecules, glycosylation, cell 
surface density of the expressed antigen, and species differences (10,  11). 
Our findings complement those of others (2-13) who have used gene manip- 
ulation, transfection, and expression to show that murine CTL are restricted by 
determinants  in  the a~  and/or  O¢  2  domains.  More importantly,  we have shown 
that the interaction  of the o/1 and c~2 domains can result in either the formation 
or  loss  of determinants  that  cannot  be  directly  correlated  with  the  primary 
structure.  Perhaps  the  most  surprising  finding  is  that  some  determinants  ex- 
pressed by both  HLA-A2 and  -Aw68 are  lost  in  the  recombinant  HLA-Aw69 
molecule.  Since  there  are  no  sequences  unique  to  HLA-Aw69,  this  finding CLAYBERGER ET  AL.  BRIEF  DEFINITIVE  REPORT  1713 
underscores the role of secondary and/or tertiary structure in the generation of 
functionally relevant epitopes, and points out the potential problem of creating 
or deleting determinants when hybrid genes are generated in vitro from genes 
that are even more disparate than HLA-A2 and -Aw68. 
Summary 
The major histocompatibility complex class I  HLA molecules are the primary 
determinants recognized by allogeneic cytotoxic T  lymphocytes (CTL), and serve 
as restricting elements for CTL  recognition of viral, chemical, or minor histo- 
compatibility antigens.  HLA-Aw69 is a  naturally occurring hybrid class I  mole- 
cule that we have used to investigate the regions of class I  antigens involved in 
human  CTL  recognition.  HLA-Aw69  appears  to  have resulted  from an  exon 
shuffle between two closely related class I  genes: the at  domain of HLA-Aw69 
is identical to that of HLA-Aw68, while the a2 and a3 domains are identical to 
HLA-A2. The determinants recognized by human allogeneic CTL clones specific 
for HLA-A2, -Aw68,  and/or -Aw69  fall into three patterns:  (a) CTL determi- 
nants are located on both the al and a2 domains; (b) interaction of the al and Og  2 
domains results in new combinatorial determinants; (c) interaction of the al and 
~2 domains in the hybrid molecule results in the loss of CTL determinants that 
are present on both parental molecules. Thus, using human CTL clones, target 
cells, and HLA molecules, we show that the interaction of the ~1 and o~ domains 
alters CTL determinants in ways not directly predictable from primary structure. 
We thank L. Herzenberg, J. Jongstra, P. Kavathas, L. Steinman, and J. Parnes for critical 
review of the manuscript, andJ. Tayabas for assistance in preparing the manuscript. 
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